 |
|
Cerebral Hemorrhage With Biopsy-Proved Amyloid Angiopathy
William H. Yong, MD;
Marie E. Robert, MD;
Diana Lenard Secor, MS;
Theodore J. Kleikamp, MD;
Harry V. Vinters, MD
Arch Neurol. 1992;49(1):51-58.
Abstract
• Clinical, radiological, and immunohistochemical findings in brain biopsy specimens from six patients with cerebral amyloid angiopathy—associated intracerebral hemorrhage were reviewed. Acute clinical presentations included headache, nausea and vomiting, loss of consciousness, and focal neurological deficits such as hemiplegia and blindness. Transient schemic attacks experienced by one patient and referable to one hemisphere did not indicate impending hemorrhage in that region. Computed tomographic scans revealed acute, irregular, superficial, lobar hemorrhage with occasional ring enhancement. Immunohistochemical studies were performed on biopsy specimens using primary antibodies against portions of the Alzheimer A4 (β-) peptide or  -trace peptide (the vascular amyloid protein in patients with hereditary cerebral hemorrhage with amyloidosis—Icelandic type). In all patients, anti-A4 and anti—-trace labeled cerebral microvessels. Immunoreactive senile plaques were few compared with the numbers of stained microvessels. Reactive astrocytes in some patients were labeled by both antiserum samples, suggesting uptake or production of these proteins by the astrocytes. This study demonstrates the heterogeneous clinical and radiological features of cerebral amyloid angiopathy—related brain hemorrhage and the value of anti-A4 and anti—-trace immunohistochemical study of biopsy material from patients with suspected cerebral amyloid angiopathy—related intraparenchymal bleeding.
Author Affiliations
From the Department of Pathology (Drs Yong, Robert, and Vinters and Ms Secor) and Brain Research Institute (Dr Vinters), UCLA School of Medicine; and Department of Neurology, St Vincent Hospital and Medical Center, Portland, Ore (Dr Kleikamp).
Footnotes
Accepted for publication August 1, 1991.
Reprint requests to Department of Pathology (Neuropathology), CHS 18-170, UCLA School of Medicine, Los Angeles, CA 90024-1732 (Dr Vinters).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Insulin-degrading Enzyme in Brain Microvessels: PROTEOLYSIS OF AMYLOID {beta} VASCULOTROPIC VARIANTS AND REDUCED ACTIVITY IN CEREBRAL AMYLOID ANGIOPATHY
Morelli et al.
J. Biol. Chem. 2004;279:56004-56013.
ABSTRACT
| FULL TEXT
Cerebral Amyloid Angiopathy Related Hemorrhage : Interaction of APOE {epsilon}2 With Putative Clinical Risk Factors
McCarron et al.
Stroke 1999;30:1643-1646.
ABSTRACT
| FULL TEXT
Cystatin C: Icelandic-Like Mutation in an Animal Model of Cerebrovascular -Amyloidosis
Wei et al.
Stroke 1996;27:2080-2085.
ABSTRACT
| FULL TEXT
|
